Lv1
60 积分 2023-10-23 加入
Neoadjuvant tislelizumab plus chemotherapy in locally advanced oral and oropharyngeal squamous cell carcinoma: A single-arm phase II clinical trial
2个月前
已完结
Pathologic Response and Survival After Neoadjuvant Immunotherapy for Resectable Mucosal HNSCC
2个月前
已关闭
Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis
2个月前
已完结
Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis
2个月前
已关闭
Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis
2个月前
已关闭
Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma
2个月前
已关闭
Derivation and validation of the AJCC9V pathological stage classification for HPV-positive oropharyngeal carcinoma: a multicentre registry analysis
2个月前
已完结
A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM Classification
3个月前
已完结
Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma
3个月前
已完结
Chemoradiotherapy vs Radiotherapy Alone in T1-2 Oropharyngeal Cancer with Low Volume Neck Disease: A Population-Based Cohort Study Utilizing the XXXXX Head and Neck Cancer Register
9个月前
已完结
皖公网安备34019202002308
